compound glp 1 news 🚨 BREAKING GLP-1 #tirzepatide #semaglutide FDA Ban on Compounded GLP-1

While extensive trials in human subjects are lacking, studies to date in both animal and human models are highly favorable

Because high-quality human data are limited, there is no universally accepted clearance time, so we emphasize individualized dosing, careful monitoring, and regular re-evaluation rather than assuming it is quickly or completely out of the system after a set number of days

Patient consent Obtained

& Landi, F., Gemelli Against COVID-19 Post-Acute Care Study Group

For drug testing purposes, standard employment drug panels do not test for peptides

OUR PRODUCTS ARE HIGH QUALITY - Everything we manufacture is manufactured and certified in the UK and protected by the world's highest manufacturing standards (GMP, BRC).